A platform for CRISPRi-seq in Streptomyces albidoflavus
ABSTRACT Streptomyces produce a multitude of secondary metabolites, which have been exploited in drug discovery campaigns for more than three-quarters of a century. Our understanding of microbial physiology has been revolutionized by genome sequencing and large-scale functional studies. Technology f...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
American Society for Microbiology
2026-02-01
|
| Ráidu: | mBio |
| Fáttát: | |
| Liŋkkat: | https://journals.asm.org/doi/10.1128/mbio.03065-25 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|